People
Tom Richardson, president of ILSE, told BioSpace that it’s a shame how New Jersey is often overlooked as a life sciences hub, particularly when a quick glance at the state’s ecosystem reveals the extensive presence of pharma, biotech and other assets of the industry.
Former commissioner of the U.S. Food and Drug Administration, Scott Gottlieb, although not running for office (that we are aware of), recently published commentary urging the United States to avoid making it more difficult for poor people to gain access to cutting-edge medications.
Anima Biotech is merging mRNA therapeutics with its own AI and bioinformatics capability. Yochi Slonim, co-founder and chief executive officer of Anima Biotech, took time to speak with BioSpace about the company and mRNA therapeutics.
The NIH program aims to recruit up to 15 investigators from diverse backgrounds each year and to provide the investigators with mentoring and other professional development activities.
Some of the biggest hubs for biotech and pharma fared poorly in the rankings due to housing affordability.
Biopharma companies add new leaders to executive roles and boards of directors.
Early detection of cardiovascular disease is becoming possible due to research from Giovanna Guidoboni, Marjorie Skubic and a team at the University of Missouri.
“ALS is a disease you really want to make a difference in,” Toby Ferguson Biogen’s senior medical director for Neuromuscular Research and Early Development told BioSpace.
Clinical Ink is pleased to announce that Jonathan Andrus, Chief Business Officer at Clinical Ink, will receive the 2019 Excellence in Service Award from the Drug Information Association’s (DIA) Americas Regional Advisory Council.
Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin
PRESS RELEASES